Literature DB >> 33162261

The next wave? Mental health comorbidities and patients with substance use disorders in under-resourced and rural areas.

Sara C Warfield1, Robert P Pack2, Louisa Degenhardt3, Sarah Larney4, Chrianna Bharat3, Lisham Ashrafioun5, Brandon D L Marshall6, Robert M Bossarte7.   

Abstract

The rapid spread of the coronavirus disease (COVID-19) has impacted the lives of millions around the globe. The COVID-19 pandemic has caused increasing concern among treatment professionals about mental health and risky substance use, especially among those who are struggling with a substance use disorder (SUD). The pandemic's impact on those with an SUD may be heightened in vulnerable communities, such as those living in under-resourced and rural areas. Despite policies loosening restrictions on treatment requirements, unintended mental health consequences may arise among this population. We discuss challenges that under-resourced areas face and propose strategies that may improve outcomes for those seeking treatment for SUDs in these areas.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  COVID-19; Rural; Substance use disorder; Treatment; Under-resourced

Mesh:

Year:  2020        PMID: 33162261      PMCID: PMC8370590          DOI: 10.1016/j.jsat.2020.108189

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  26 in total

Review 1.  Management of opioid use disorder in the USA: present status and future directions.

Authors:  Carlos Blanco; Nora D Volkow
Journal:  Lancet       Date:  2019-03-14       Impact factor: 79.321

2.  Innovations in efforts to expand treatment for opioid use disorder.

Authors:  Stacey C Sigmon
Journal:  Prev Med       Date:  2019-08-21       Impact factor: 4.018

3.  Prevalence, patterns, and correlates of co-occurring substance use and mental disorders in the United States: variations by race/ethnicity.

Authors:  Amy A Mericle; Van M Ta Park; Peter Holck; Amelia M Arria
Journal:  Compr Psychiatry       Date:  2011-12-05       Impact factor: 3.735

4.  Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study.

Authors:  Marina Davoli; Anna M Bargagli; Carlo A Perucci; Patrizia Schifano; Valeria Belleudi; Matthew Hickman; Giuseppe Salamina; Roberto Diecidue; Federica Vigna-Taglianti; Fabrizio Faggiano
Journal:  Addiction       Date:  2007-12       Impact factor: 6.526

5.  Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.

Authors:  Bridget F Grant; Frederick S Stinson; Deborah A Dawson; S Patricia Chou; Mary C Dufour; Wilson Compton; Roger P Pickering; Kenneth Kaplan
Journal:  Arch Gen Psychiatry       Date:  2004-08

Review 6.  Mortality among people who inject drugs: a systematic review and meta-analysis.

Authors:  Bradley M Mathers; Louisa Degenhardt; Chiara Bucello; James Lemon; Lucas Wiessing; Mathew Hickman
Journal:  Bull World Health Organ       Date:  2013-02-01       Impact factor: 9.408

7.  Substance Use in Rural Central Appalachia: Current Status and Treatment Considerations.

Authors:  Lara Moody; Emily Satterwhite; Warren K Bickel
Journal:  Rural Ment Health       Date:  2017-04

Review 8.  Addiction psychiatry and COVID-19: impact on patients and service provision.

Authors:  D Columb; R Hussain; C O'Gara
Journal:  Ir J Psychol Med       Date:  2020-05-21

Review 9.  Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science.

Authors:  Emily A Holmes; Rory C O'Connor; V Hugh Perry; Irene Tracey; Simon Wessely; Louise Arseneault; Clive Ballard; Helen Christensen; Roxane Cohen Silver; Ian Everall; Tamsin Ford; Ann John; Thomas Kabir; Kate King; Ira Madan; Susan Michie; Andrew K Przybylski; Roz Shafran; Angela Sweeney; Carol M Worthman; Lucy Yardley; Katherine Cowan; Claire Cope; Matthew Hotopf; Ed Bullmore
Journal:  Lancet Psychiatry       Date:  2020-04-15       Impact factor: 27.083

10.  COVID-19 During the Opioid Epidemic - Exacerbation of Stigma and Vulnerabilities.

Authors:  Wiley D Jenkins; Rebecca Bolinski; John Bresett; Brent Van Ham; Scott Fletcher; Suzan Walters; Samuel R Friedman; Jerel M Ezell; Mai Pho; John Schneider; Larry Ouellet
Journal:  J Rural Health       Date:  2020-06-01       Impact factor: 5.667

View more
  6 in total

1.  Associations Between Substance Use Problems and Stress During COVID-19.

Authors:  Erin A Vogel; Amy Chieng; Athena Robinson; Sarah Pajarito; Judith J Prochaska
Journal:  J Stud Alcohol Drugs       Date:  2021-11       Impact factor: 2.582

2.  Priority Given to Technology in Government-Based Mental Health and Addictions Vision and Strategy Documents: Systematic Policy Review.

Authors:  Shalini Lal; Lyna Siafa; Hajin Lee; Carol E Adair
Journal:  J Med Internet Res       Date:  2021-05-05       Impact factor: 5.428

Review 3.  Suicidal Behavior in the First Wave of the COVID-19 Pandemic.

Authors:  Lucas Giner; Constanza Vera-Varela; Diego de la Vega; Giovani M Zelada; Julio A Guija
Journal:  Curr Psychiatry Rep       Date:  2022-01-26       Impact factor: 8.081

4.  Using qualitative, community-based input to steer post-coronavirus disease 2019 pharmacy practice in substance use.

Authors:  Lucas Kosobuski; Andrew Hawn; Katelyn France; Nathaniel Chen; Cierra LaPlante; Laura Palombi
Journal:  J Am Pharm Assoc (2003)       Date:  2022-03-19

5.  Longitudinal Correlates of Suicide Ideation in People who use Drugs during the COVID-19 Pandemic.

Authors:  Kasey Claborn; Elizabeth Lippard; Fiona Conway
Journal:  Res Sq       Date:  2022-08-26

6.  Mental health nursing practice in rural and remote Canada: Insights from a national survey.

Authors:  Martha L P MacLeod; Kelly L Penz; Davina Banner; Sharleen Jahner; Irene Koren; Alexandra Thomlinson; Pertice Moffitt; Mary Ellen Labrecque
Journal:  Int J Ment Health Nurs       Date:  2021-10-19       Impact factor: 5.100

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.